Martin, E.B.; Stuckey, A.; Powell, D.; Lands, R.; Whittle, B.; Wooliver, C.; Macy, S.; Foster, J.S.; Guthrie, S.; Kennel, S.J.;
et al. Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging. Pharmaceuticals 2023, 16, 629.
https://doi.org/10.3390/ph16040629
AMA Style
Martin EB, Stuckey A, Powell D, Lands R, Whittle B, Wooliver C, Macy S, Foster JS, Guthrie S, Kennel SJ,
et al. Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging. Pharmaceuticals. 2023; 16(4):629.
https://doi.org/10.3390/ph16040629
Chicago/Turabian Style
Martin, Emily B., Alan Stuckey, Dustin Powell, Ronald Lands, Bryan Whittle, Craig Wooliver, Sallie Macy, James S. Foster, Spencer Guthrie, Stephen J. Kennel,
and et al. 2023. "Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging" Pharmaceuticals 16, no. 4: 629.
https://doi.org/10.3390/ph16040629
APA Style
Martin, E. B., Stuckey, A., Powell, D., Lands, R., Whittle, B., Wooliver, C., Macy, S., Foster, J. S., Guthrie, S., Kennel, S. J., & Wall, J. S.
(2023). Clinical Confirmation of Pan-Amyloid Reactivity of Radioiodinated Peptide 124I-p5+14 (AT-01) in Patients with Diverse Types of Systemic Amyloidosis Demonstrated by PET/CT Imaging. Pharmaceuticals, 16(4), 629.
https://doi.org/10.3390/ph16040629
